Cancer diagnostics - 1 News by Heidelberg Epignostix from Germany for the diagnostics industry

Cancer diagnostics - 1 News by Heidelberg Epignostix from Germany for the diagnostics industry

image description

DKFZ spin-off Epignostix raises €4.3m seed round to commercialize diagnostic tumor classifier

Precise cancer classification of subtypes that are otherwise difficult or impossible to distinguish

16-Jul-2024 - Heidelberg Epignostix GmbH, a deeptech start-up committed to precision cancer diagnostics announces €4.3M in seed funding. This investment will enable Heidelberg Epignostix to make a substantial leap forward in driving market development for its flagship indication for brain tumor ...

cancer diagnostics artificial intelligence bioinformatics

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

1 products
1 whitepaper
1 brochures
View topic world
Topic world Diagnostics

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

1 products
1 whitepaper
1 brochures
View topic world
Haven't found the right news yet?

The bionity.com news search

Start your targeted search now with a wide range of filter options. Our database includes an archive of 27,243 life science news from business and science, which you can search by topic and organization, filtered by time and geography.

Start news search now